Consolidated Portfolio Review Corp Edwards Lifesciences Corp Transaction History
Consolidated Portfolio Review Corp
- $796 Billion
- Q3 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 2,780 shares of EW stock, worth $239,914. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,780Holding current value
$239,914% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EW
# of Institutions
1,457Shares Held
468MCall Options Held
3.49MPut Options Held
4.09M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...